Rebecca Poehnelt, Senior Director, US Oncology Portfolio Strategy and Execution at Johnson & Johnson Innovative Medicine, shared on LinkedIn:
“I’m excited to share an opportunity to join the Johnson and Johnson US Oncology team as Senior Director, Precision Medicine, US Oncology.
This is a highly strategic leadership role focused on shaping and executing our precision medicine agenda, advancing biomarker testing and patient identification strategies, and partnering across Commercial, Medical, R/D, and other functions to help bring more personalized care to patients with cancer.”
Other articles about Precision Medicine on OncoDaily.